Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Rheumatol Int ; 33(5): 1201-6, 2013 May.
Artigo em Inglês | MEDLINE | ID: mdl-22983137

RESUMO

The vessel sclerosing property of sodium morrhuate is useful in treatment of recurrent joint effusions particularly in cases of knee joint effusions. It also can be employed as an addition to surgical synovectomy. Little is known about the effects of this drug on cartilage. This study was designed to investigate the cytotoxic impact of sodium morrhuate on human chondrocytes and cartilage tissue in vitro. Primary chondrocytes from 13 patients were isolated and cultivated in three-dimensional alginate cultures. Furthermore, femoral cartilage explants of 10 patients were cultivated in vitro. Both chondrocytes and cartilage explants were exposed to mixture of sodium morrhuate and mepivacaine in different concentrations simulating chemical synovectomy. After 48 h, cell proliferation, viability, and cytotoxicity were measured. The cartilage specimens were analyzed for apoptosis by immunohistochemistry. Up to a dilution of 1:600, cells were found to be 100 % viable with a proliferation rate of 74 % compared to controls. From 1:400 onwards, a significant increase in LDH release was measured which reached at dilution of 1:200 74 % of high control, whereas histological examination showed no proof of apoptosis or necrosis in cartilage tissue. The results of this in vitro study demonstrate that the cytotoxic effects of sodium morrhuate on human chondrocytes, which lack their original extracellular matrix, manifest between dilutions of 1:500 and 1:400 and increase with higher concentrations of the drug. This effect was not found for cartilage explants, though.


Assuntos
Cartilagem Articular/efeitos dos fármacos , Condrócitos/efeitos dos fármacos , Soluções Esclerosantes/farmacologia , Escleroterapia/métodos , Morruato de Sódio/farmacologia , Idoso , Apoptose/efeitos dos fármacos , Cartilagem Articular/patologia , Proliferação de Células/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Condrócitos/patologia , Relação Dose-Resposta a Droga , Feminino , Humanos , Imuno-Histoquímica , Masculino , Mepivacaína/farmacologia , Pessoa de Meia-Idade , Necrose , Cultura Primária de Células , Soluções Esclerosantes/toxicidade , Escleroterapia/efeitos adversos , Morruato de Sódio/toxicidade , Fatores de Tempo , Técnicas de Cultura de Tecidos
2.
Infect Immun ; 49(1): 141-4, 1985 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-3924826

RESUMO

Arachidonic acid was used as a facilitating agent in experimental rat Staphylococcus aureus osteomyelitis and compared with the more commonly used agent, sodium morrhuate. The injection of arachidonic acid or sodium morrhuate and S. aureus into rat tibiae caused increased quantitative bacterial bone counts, gross bone pathology, roentgenographic changes, and weight loss. The doses required to produce these changes appeared to be lower for arachidonic acid.


Assuntos
Ácidos Araquidônicos/toxicidade , Osteomielite/etiologia , Animais , Ácido Araquidônico , Técnicas de Cultura , Modelos Animais de Doenças , Osteomielite/diagnóstico por imagem , Osteomielite/patologia , Radiografia , Ratos , Morruato de Sódio/toxicidade , Infecções Estafilocócicas/complicações , Staphylococcus aureus/patogenicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA